A Comprehensive Inter-Tissue Crosstalk Analysis Underlying Progression and Control of Obesity and Diabetes

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Samdani, Pawan ^a   Singhal, Meet ^a   Sinha, Neeraj ^b   Tripathi, Parul ^b   Sharma, Sachin ^b   Tikoo, Kamiya ^b   Rao, Kanury V S ^b   Kumar, Dhiraj ^b  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAT INTAKE; PROTEOME; SUGAR INTAKE;

ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; COMPLICATION; COMPUTER SIMULATION; DIABETES MELLITUS; DISEASE COURSE; FAT INTAKE; LIPID DIET; METABOLISM; MOUSE; OBESITY; PROCEDURES; SUGAR INTAKE; TISSUE DISTRIBUTION;

ANIMALS; COMPUTER SIMULATION; DIABETES MELLITUS; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUCROSE; DISEASE PROGRESSION; MICE; MODELS, BIOLOGICAL; OBESITY; ORGAN SPECIFICITY; PROTEOME; TISSUE DISTRIBUTION;

EID: 84937842509     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12340     Document Type: Article

References (28)

1. Swinburn, B. A. et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378, 804-814 (2011).
2. Lee, D. E., Kehlenbrink, S., Lee, H., Hawkins, M. , Yudkin, J. S. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 296, E1210-1229 (2009).
3. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
4. Rankinen, T. et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 14, 529-644 (2006).
5. Rosen, E. D. , Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847-853 (2006).
6. Gregor, M. F. , Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415-445 (2011).
7. Trayhurn, P. , Wood, I. S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92, 347-355 (2004).
8. Collins, S., Martin, T. L., Surwit, R. S. , Robidoux, J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81, 243-248 (2004).
9. Tikoo, K., Misra, S., Rao, K. V., Tripathi, P. , Sharma, S. Immunomodulatory Role of an Ayurvedic Formulation on Imbalanced Immunometabolics during Inflammatory Responses of Obesity and Prediabetic Disease. Evid Based Complement Alternat Med 2013, 795072 (2013).
10. Sinha, N. et al. Molecular signatures for obesity and associated disorders identified through partial least square regression models. BMC Syst Biol 8, 104 (2014).
11. Aranda, B. et al. PSICQUIC and PSISCORE: accessing and scoring molecular interactions. Nat Methods 8, 528-529 (2011).
12. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498-2504 (2003).
13. Eckardt, K., Taube, A. , Eckel, J. Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. Rev Endocr Metab Disord 12, 163-172 (2011).
14. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation 112, 1796-1808 (2003).
15. Martin, A. A. , Davidson, T. L. Human cognitive function and the obesogenic environment. Physiol Behav 136, 185-193 (2014).
16. Lin, S., Boey, D. , Herzog, H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38, 189-200 (2004).
17. Ouchi, N. et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329, 454-457 (2010).
18. Catalan, V. et al. Increased tenascin C and Toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity. J Clin Endocrinol Metab 97, E1880-1889 (2012).
19. Egusa, G., Beltz, W. F., Grundy, S. M. , Howard, B. V. Influence of obesity on the metabolism of apolipoprotein B in humans. The Journal of clinical investigation 76, 596-603 (1985).
20. Mathes, W. F. et al. Dopaminergic dysregulation in mice selectively bred for excessive exercise or obesity. Behav Brain Res 210, 155-163 (2010).
21. Canto, C. et al. Neuregulin signaling on glucose transport in muscle cells. J Biol Chem 279, 12260-12268 (2004).
22. Marzolo, M. P. , Farfan, P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res 44, 89-105 (2011).
23. Mii, A. et al. Genetic association of low-density lipoprotein receptor-related protein 2 (LRP2) with plasma lipid levels. J Atheroscler Thromb 14, 310-316 (2007).
24. Strickland, D. K., Gonias, S. L. , Argraves, W. S. Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13, 66-74 (2002).
25. Ma, L. J. et al. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53, 336-346 (2004).
26. Sawane, M. et al. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 62, 1970-1980 (2013).
27. Lowell, B. B. et al. Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366, 740-742 (1993).
28. Virtanen, K. A. et al. Functional brown adipose tissue in healthy adults. N Engl J Med 360, 1518-1525 (2009).